A Comparative Study of KW-2246

NCT01326689 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Cancer Related Pain (Breakthrough Pain)

Interventions

DRUG: KW-2246
DRUG: Placebo

Sponsor

Kyowa Kirin Co., Ltd.